Keros Therapeutics director Charles W. Newton reports sale of 551 shares for $5,980.53
KROS•Director Charles W. Newton sold 551 Keros Therapeutics common shares on November 17, 2026, for $5,980.53, reducing his direct beneficial ownership to 11,563 shares.




